No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Defence Provides Update on Delivery of AGSM Proxy Materials
Defence Announces Dr. Maxime Parisotto as CSO, Director of Science and Business Development
Defence Announces Radiopharmaceutical Expert Svetlana Selivanova Joins Board of Directors
Defence Announces Extension of Private Placement, Continues Development of Its Radiopharmaceuticals and ADC Programs
Defence's Corporate Updates, Arranges Financing
Defence Therapeutics Inc: MDA EN
No Data